# Wei-Wu He

> Wei-Wu He is a post-ipo equity investor at Origene Technologies backing Chemical and CleanTech. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Origene Technologies](https://shizune.co/investors/profile/origene-technologies)
- Location: Rockville, United States
- Total investments: 1
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/wei-wu-he-b6957313

Wei-Wu He is a post-ipo equity investor at Origene Technologies in Rockville focused on Chemical and CleanTech. Wei-Wu He - Founder and CEO @ Origene Technologies

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Chemical | 1 | 100% |
| CleanTech | 1 | 100% |
| Biotechnology | 1 | 100% |
| Renewable Energy | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Amyris | Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and producespecialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals. | $34M | Post-IPO Equity | Apr 30, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Foris Ventures](https://shizune.co/investors/profile/foris-ventures) — VC Fund, 1 deal together

## About Origene Technologies

VC Fund · Rockville, United States

OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs. It strives to fulfill its mission of supplying everything a researcher needs for gene-based research. Through licensing and selling research materials including genes, proteins, and research tools, itenables critical biological research.

1 contacts available at Origene Technologies.

| Name | Title | Profile |
| --- | --- | --- |
| Wei-Wu He | Founder and CEO | https://shizune.co/investors/profile/wei-wu-he |

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does Wei-Wu He invest in?

Wei-Wu He invests primarily in Chemical, CleanTech and Biotechnology startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co